CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,272,620 | +144.0% | 59,152 | +47.0% | 0.00% | – |
Q1 2023 | $931,580 | +3232.3% | 40,241 | +3671.4% | 0.00% | – |
Q4 2022 | $27,956 | -3.6% | 1,067 | -26.9% | 0.00% | – |
Q3 2022 | $29,000 | +70.6% | 1,460 | +48.8% | 0.00% | – |
Q2 2022 | $17,000 | -72.1% | 981 | -73.7% | 0.00% | – |
Q1 2022 | $61,000 | -78.4% | 3,737 | -78.4% | 0.00% | – |
Q4 2021 | $282,000 | -59.1% | 17,263 | -68.1% | 0.00% | – |
Q3 2021 | $690,000 | +248.5% | 54,123 | +285.1% | 0.00% | – |
Q2 2021 | $198,000 | -83.2% | 14,054 | -81.5% | 0.00% | – |
Q1 2021 | $1,178,000 | +28.9% | 75,765 | +31.5% | 0.00% | – |
Q4 2020 | $914,000 | – | 57,622 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 5 | $0 | 0.00% |